0001209191-21-071007.txt : 20211222 0001209191-21-071007.hdr.sgml : 20211222 20211222210020 ACCESSION NUMBER: 0001209191-21-071007 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211220 FILED AS OF DATE: 20211222 DATE AS OF CHANGE: 20211222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Legault Pierre CENTRAL INDEX KEY: 0001391045 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38916 FILM NUMBER: 211514584 MAIL ADDRESS: STREET 1: P.O. BOX 1028 STREET 2: C/O STONE MANAGEMENT LLC CITY: BERWYNE STATE: PA ZIP: 19312 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BICYCLE THERAPEUTICS plc CENTRAL INDEX KEY: 0001761612 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: B900 BABRAHAM RESEARCH CAMPUS CITY: CAMBRIDGE STATE: X0 ZIP: CB22 3AT BUSINESS PHONE: 011441223261503 MAIL ADDRESS: STREET 1: B900 BABRAHAM RESEARCH CAMPUS CITY: CAMBRIDGE STATE: X0 ZIP: CB22 3AT FORMER COMPANY: FORMER CONFORMED NAME: BICYCLE THERAPEUTICS Ltd DATE OF NAME CHANGE: 20181212 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-12-20 0 0001761612 BICYCLE THERAPEUTICS plc BCYC 0001391045 Legault Pierre C/O BICYCLE THERAPEUTICS PLC B900, BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT UNITED KINGDOM 1 0 0 0 Ordinary Shares 2021-12-20 4 M 0 7603 8.41 A 7603 D Ordinary Shares 2021-12-20 4 S 0 7603 57.02 D 0 D Ordinary Shares 2021-12-21 4 M 0 44537 8.44 A 44537 D Ordinary Shares 2021-12-21 4 S 0 44537 57.11 D 0 D Ordinary Shares 2021-12-22 4 M 0 97860 8.48 A 97860 D Ordinary Shares 2021-12-22 4 S 0 97860 58.01 D 0 D Stock Option (Right to Buy) 8.41 2021-12-20 4 M 0 7603 0.00 D 2029-04-25 Ordinary Shares 7603 165709 D Stock Option (Right to Buy) 8.44 2021-12-21 4 M 0 44537 0.00 D 2029-04-25 Ordinary Shares 44537 121172 D Stock Option (Right to Buy) 8.48 2021-12-22 4 M 0 97860 0.00 D 2029-04-25 Ordinary Shares 97860 23312 D This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.319915 to GBP 1.00 as of December 20, 2021. Shares were sold pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.00 to $57.05 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (5) and (7). This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.324735 to GBP 1.00 as of December 21, 2021. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.02 to $57.55 inclusive. This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.331495 to GBP 1.00 as of December 22, 2021. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.51 to $58.50 inclusive. This option shall vest in 36 equal monthly installments and shall be fully vested on March 15, 2022. /s/ Lee Kalowski, Attorney-in-Fact 2021-12-22